SEARCH

SEARCH BY CITATION

References

  • 1
    Sangha O ( 2000) Epidemiology of rheumatic diseases. Rheumatology 2: 312.
  • 2
    Pedersen JK, Kjaer NK, Svendsen AJ, Horslev-Petersen K ( 2009) Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources. Rheumatol Int 4: 411415.
  • 3
    Bridges SL ( 2004) Update on autoantibodies in rheumatoid arthritis. Curr Rheumatol Rep 6: 343350.
  • 4
    Uysal H, Nandakumar KS, Kessel C, Haag S, Carlsen S, Burkhardt H, Holmdahl R ( 2010) Antibodies to citrullinated proteins: molecular interactions and arthritogenicity. Immunol Rev 233: 933.
  • 5
    Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Holers VM ( 2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116: 961973.
  • 6
    Trouw LA, Haisma EM, Levarht EW, van der Woude D, Ioan-Facsinay A, Daha MR, Huizinga TW, Toes RE ( 2009) Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 60: 19231931.
  • 7
    Uysal H, Bockermann R, Nandakumar KS, Sehnert B, Bajtner E, Engstrom A, Serre G, Burkhardt H, Thunnissen MM, Holmdahl R ( 2009) Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 206: 449462.
  • 8
    van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ ( 2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4: 8793.
  • 9
    Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ ( 1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101: 273281.
  • 10
    van Venrooij WJ, Pruijn GJ ( 2000) Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2: 249251.
  • 11
    Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R ( 2005) Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 35: 16431652.
  • 12
    Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, Moyes D, Taylor PC, Venables PJ ( 2005) Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 7: R1421R1429.
  • 13
    Takizawa Y, Suzuki A, Sawada T, Ohsaka M, Inoue T, Yamada R, Yamamoto K ( 2006) Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis 65: 10131020.
  • 14
    Vossenaar ER, Despres N, Lapointe E, van der Heijden A, Lora M, Senshu T, van Venrooij WJ, Menard HA ( 2004) Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6: R142R150.
  • 15
    Union A, Meheus L, Humbel RL, Conrad K, Steiner G, Moereels H, Pottel H, Serre G, De KF ( 2002) Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. Arthritis Rheum 46: 11851195.
  • 16
    Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, van der Woude D, Elias B, Menard HA, Newkirk M, Fritzler MJ, Toes RE, Huizinga TW, El-Gabalawy HS ( 2008) Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 58: 30003008.
  • 17
    Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Ronnelid J, Rantapaa-Dahlqvist S ( 2011) Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther 13: R13.
  • 18
    Li W, Wang M, Irigoyen P, Gregersen PK ( 2006) Inferring causal relationships among intermediate phenotypes and biomarkers: a case study of rheumatoid arthritis. Bioinformatics 22: 15031507.
  • 19
    Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ ( 2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48: 27412749.
  • 20
    Coenen D, Verschueren P, Westhovens R, Bossuyt X ( 2007) Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem 53: 498504.
  • 21
    Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ ( 2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43: 155163.
  • 22
    Wiik AS, van Venrooij WJ, Pruijn GJ ( 2010) All you wanted to know about anti-CCP but were afraid to ask. Autoimmun Rev 10: 9093.
  • 23
    Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G ( 2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62: 25692581.
  • 24
    Szodoray P, Szabo Z, Kapitany A, Gyetvai A, Lakos G, Szanto S, Szucs G, Szekanecz Z ( 2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 9: 140143.
  • 25
    Perez ML, Gomara MJ, Ercilla G, Sanmarti R, Haro I ( 2007) Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis. J Med Chem 50: 35733584.
  • 26
    Malakoutikhah M, Gomara MJ, Gomez-Puerta JA, Sanmarti R, Haro I ( 2011) The use of chimeric vimentincitrullinated peptides for the diagnosis of rheumatoid arthritis. J Med Chem 54: 74867492.
  • 27
    Soos L, Szekanecz Z, Szabo Z, Fekete A, Zeher M, Horvath IF, Danko K, Kapitany A, Vegvari A, Sipka S, Szegedi G, Lakos G ( 2007) Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol 34: 16581663.
  • 28
    Kobylyansky AG, Nekrasov AN, Kozlova VI, Sandin MY, Alikhanov BA, Demkin VV ( 2011) Detection of new epitopes of antibodies to filaggrin in filaggrin protein molecule. Bull Exp Biol Med 151: 615618.
  • 29
    Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, Mikuls TR, Venables PJ ( 2008) Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 58: 30093019.
  • 30
    Perez ML, Gomara MJ, Ercilla G, Sanmarti R, Haro I ( 2007) Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis. J Med Chem 50: 35733584.
  • 31
    Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, Roudier J, Serre G ( 2006) Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 36: 22502263.
  • 32
    Willemze A, Bohringer S, Knevel R, Levarht EW, Stoeken-Rijsbergen G, Houwing-Duistermaat JJ, Van der Helm-van Mil AH, Huizinga TW, Toes RE, Trouw LA ( 2012) The ACPA recognition profile and subgrouping of ACPA-positive RA patients. Ann Rheum Dis 71: 268274.
  • 33
    Ioan-Facsinay A, El-Bannoudi H, Scherer HU, van der Woude D, Menard HA, Lora M, Trouw LA, Huizinga TW, Toes RE ( 2011) Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis 70: 188193.
  • 34
    van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, Drijfhout JW, Huizinga TW, Toes RE, Pruijn GJ ( 2010) Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis 69: 15541561.
  • 35
    Williamson MP, Handa BK, Hall MJ ( 1986) Secondary structure of a herpes simplex virus glycoprotein D antigenic domain. Int J Pept Protein Res 27: 562568.
  • 36
    Dyson HJ, Wright PE ( 1995) Antigenic peptides. FASEB J 9: 3742.
  • 37
    Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM ( 1996) Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 271: 3070930716.
  • 38
    Dorow DS, Shi PT, Carbone FR, Minasian E, Todd PE, Leach SJ ( 1985) Two large immunogenic and antigenic myoglobin peptides and the effects of cyclisation. Mol Immunol 22: 12551264.
  • 39
    Mydel P, Wang Z, Brisslert M, Hellvard A, Dahlberg LE, Hazen SL, Bokarewa M ( 2010) Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol 184: 68826890.
  • 40
    Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, Levarht NE, van der Helm-van Mil AH, Cerami A, Huizinga TW, Toes RE, Trouw LA ( 2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A 108: 1737217377.
  • 41
    Shoda H, Fujio K, Shibuya M, Okamura T, Sumitomo S, Okamoto A, Sawada T, Yamamoto K ( 2011) Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis. Arthritis Res Ther 13: R191.
  • 42
    Trier NH, Hansen PR, Vedeler CA, Somnier FE, Houen G ( 2012) Identification of continuous epitopes of HuD antibodies related to paraneoplastic diseases/small cell lung cancer. J Neuroimmunol 243: 2533.